ENUSAU
Close Close Nav Takeover

NHS Wales

Mass vaccination programme

NHS Wales – Mass Vaccination Programme – Acceleration
Client Cardiff and Vale University Health Board NHS Wales
Region UK
Sector Public Sector, Health and Not For Profit
Offering Organisation Change & Implementation

The Challenge

Cardiff and Vale University Health Board (CAV) needed to rapidly increase the capacity of its Mass Vaccination Programme (MVP) while maintaining flexibility to respond to an unpredictable vaccine supply. In a complex environment involving multiple organisations, Q5 were asked to lead the process to develop options for accelerating the MVP and support the swift implementation of the chosen solution.​

Our Approach

Q5 quickly stood up a team in response to the challenge, forming an integrated team across Q5, CAV, and local government bodies Cardiff Council and Vale of Glamorgan Council. The team led a 14-day rapid sprint to ideate, evaluate, and shortlist options for accelerating the pace of the vaccination programme, to be taken forward to implementation by the Health Board.​​

The sprint provided both focused outcomes that provided incremental improvements to existing processes, patient flow, and capacity within the MVP as well as radical options for significant vaccination acceleration.​​

Our approach to the sprint included: ​

  • Conducting research on international best practice, forging mutually beneficial relationships with healthcare providers leading vaccination rollouts in the US, Israel, and England, and applying their learnings to the programme in Wales.​
  • Creating a data model to support programme decision making, simulating delivery scenarios and their impact on the completion of the programme.​
  • Creating a PMO team that underpinned the entire project, providing central coordination of risks and interdependencies, and driving fast-paced activity across all workstreams. ​
  • Leading the development of the acceleration programme’s key deliverables, including Executive reports and options proposals to senior local and national government leaders – setting out a number of innovative options to increase capacity at pace.​
  • Supporting patient and clinical flow design within the existing Mass Vaccination Centre, increasing space utilisation efficiency by 20% on previous designs.​

Key Outcomes

  • The main outcome of the sprint was the successful, on-time launch of Wales’ largest vaccination centre (the chosen option for acceleration), providing the Health Board with the capacity and flexibility to expand the vaccination programme and respond flexibly to a rapidly shifting vaccine supply.
  • CAV’s vaccination capacity increased by 150% to over 10k vaccinations per day, ensuring that the rollout was only constrained by vaccine supply levels.
  • The collaborative approach between Q5, CAV and local government was celebrated as a major success for partnership working across public and private sectors.
  • The Q5-developed data model ensured that decisions were taken in full view of the effect they would have on the speed of the vaccine rollout.
  • The rhythm, governance and innovative ways of working developed by the PMO team were viewed as instrumental to the programme’s success. As a result, Q5 were asked to continue our support of the Mass Vaccination Programme towards its completion.​ ​
Case studies

Discover more client stories

View all
NHS Wales – Mass Vaccination Programme – Overall Programme Direction​

Supported NHS Wales in creating a supply model to implement and monitor their COVID-19 Vaccine roll out at the largest vaccination centre in Wales for c.500,000 people.
NHS New Hospitals Programme

The NHP has been tasked with supporting Trust Project Teams in building 48 hospitals by 2030, before becoming an established organisation that will support with the future specification and building of all new hospitals across England.
NHS Wales – Future Immunisation Service Operating Model Design​

Following the success of the Covid Mass Vaccination Programme, Cardiff and Vale University Health Board (CAV UHB) were looking to build on the capabilities and lessons learned from the Mass Vaccination Programme to develop a new operating model for all immunisation services offered by CAV UHB, including the Health Board’s partners. Q5 were asked to assist with the creation of new governance structures and design the resulting transformation programme of work.

Get in touch with our experts

Contact us

logo

Q5 is a trading name of Q5 Ltd, which is registered in England and Wales, Registration No. 15266902.
The Registered Office is Thorney House, 34 Smith Square, London, England, SW1P 3HL.